Y. Ren

Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms

M. Li, X. Liu, X. Jiang, 2016, Cell Death and Disease.

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

Wenxi Tang, Mingye Zhao, Y. Ren, 2022, Frontiers in Public Health.

Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option

Z. Fan, Yuan-Yuan Wang, X. Kong, 2022, Frontiers in Immunology.

Adjuvant radiotherapy for positive lymph nodes of oesophageal squamous cell carcinoma: Can it earn promising benefits at long-term follow-up?

J. Zuo, M. Tan, W. Xiong, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Pulmonary small lymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma.

O. Tawfik, S. Pingleton, Y. Ren, 2001, Chest.

Observation on serum anti-double stranded DNA antibodies of tripterine in systemic lupus erythematosus of (NZB×W)F1 mice

X. Xu, C. Xu, Y. Ren, 2003, Annals of the rheumatic diseases.

MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study

K. Wang, L. Zhang, Y. Ren, 2014, Cell Death and Disease.

[Study on the effects of target-silencing CXCR3 expression on malignant proliferation of hepatocellular carcinoma].

L. Kong, Y. Ren, Y. Kan, 2018, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.